Skyline Ventures Adds Director, Opens Boston Office

Palo Alto-based Skyline Ventures, a $450M venture fund focused on medical devices and life sciences, said Tuesday that it has added Stephen J. Hoffman as a Managing Director, and will open up a satellite office in Boston. Hoffman was most recently at TVM Capital, and has also served as Chairman of Allos Therapeutics. According to Skyline, while at TVM Hoffman co-led the firm's investments in Boston area firms Sirtris Pharmaceuticals, Proteon Therapeutics, and Concert Pharmaceuticals. More information »